A health warning about a “rise” in poisonings can sound clinical—until you remember what it actually means on the ground: families rushing to emergency departments, 911 calls spiking, and people who use drugs trying to guess what will kill them before their bodies do. Personally, I think the most disturbing part of these alerts isn’t just the numbers or the specific substances; it’s the feeling that the system is always reacting to chaos that the public never fully sees.
Over the past week in Surrey and White Rock, Fraser Health flagged increased unregulated toxic drug poisonings, noting more 911 calls and more emergency-room visits than usual, while also saying it’s not clear how many were fatal. What makes this particularly fascinating—and frightening—is that the supply is described as both unpredictable and constantly changing, which turns harm reduction into a moving target rather than a stable safety net. From my perspective, this is what “illicit drug” reporting often hides: the crisis isn’t merely that dangerous substances exist, it’s that the combinations and potencies evolve faster than society can respond.
When prevention can’t keep up
The warning points to a grim pattern: uncertainty about what’s in the drugs and, therefore, uncertainty about how to respond. Fraser Health officials said they couldn’t say exactly what substances were found, but they referenced high-potency ingredients such as different benzodiazepines, opioids (including carfentanil), and tranquilizers. Personally, I think the inclusion of multiple categories matters because it suggests overdoses may be driven by layered risk, not a single “headline” toxin.
What people often misunderstand about drug poisoning risk is that it’s not one consistent enemy. If someone’s supply shifts toward sedatives that don’t respond to naloxone, then even the most well-intentioned interventions can lose effectiveness. This raises a deeper question: if the standard toolkit is partly built around opioid reversal, what happens when the crisis changes its main mechanism faster than harm reduction programs can adapt?
Here’s a detail I find especially interesting: advocate Rosa Sundar-Maccagno, executive director of the Surrey Union of Drug Users, said members noticed the supply being cut with more non-opioid sedatives over the past two weeks. In my opinion, that’s the kind of “on-the-ground intelligence” public agencies need more of—not as a supplement, but as a core ingredient of policy.
Naloxone isn’t powerless—but it isn’t universal
Fraser Health’s statement and the advocate’s comments converge on a key insight: some poisonings may involve drugs that naloxone can’t reverse. Personally, I think this is where public messaging can unintentionally mislead. Naloxone is lifesaving for many opioid-related overdoses, but when people hear “a reversal drug exists,” they can start to believe the danger is now neatly controlled.
What makes this particularly concerning is the possibility of higher sedation levels—Sundar-Maccagno described stronger sedation people are experiencing, potentially linked to veterinary tranquilizers or other sedatives. From my perspective, the term “veterinary” adds an extra layer of horror because it signals how normalized the repurposing of animal drugs has become in the illicit supply chain. This suggests traffickers and sellers aren’t just mixing substances; they’re improvising potency and effect in ways that health systems may not anticipate.
One thing that immediately stands out is how the harm-reduction strategy needs to evolve from “one drug, one response” to “a spectrum of risks, a spectrum of interventions.” If sedation is a major driver, then we may need broader readiness—training, assessment protocols in emergency settings, and possibly expanded community-level tools—rather than relying on any single countermeasure.
Drug checking gaps make uncertainty worse
Another critical theme is access. The advocate said availability of drug checking services is more limited in Surrey, making it especially hard for people to know what they’re taking. Personally, I think this is an underappreciated structural inequality: even within the same province, safety resources don’t distribute evenly, which means some neighborhoods live with higher uncertainty by default.
Drug checking isn’t a cure-all, but it changes the psychological terrain. When people can test, they can at least reduce guesswork; when they can’t, every dose becomes a gamble. What many people don’t realize is that uncertainty itself increases risk—because it pushes people toward either avoidance of testing (due to inconvenience), or experimentation (due to lack of alternatives), or both.
If you take a step back and think about it, this is a broader trend: public health interventions often look uniform on paper while behaving unevenly in real life. The policy implication is straightforward but politically difficult—expanding services like drug checking may not produce dramatic headlines, yet it reduces preventable harm.
The “10-year emergency” trap
B.C. declared a public health emergency related to toxic drug deaths ten years ago, and more than 18,000 people have died since then. Annual deaths have trended down slightly in recent years, but the sense of progress can be fragile—because a slight reduction can still leave a catastrophic baseline of loss. Personally, I think the most painful part of the long timeline is psychological: society begins to treat the crisis as “ongoing,” which can quietly dampen urgency.
Sundar-Maccagno described hope from earlier decriminalization efforts that later got rolled back in parts before the pilot ended on Jan. 31. In my opinion, this back-and-forth signals a political pattern: governments want the benefits of experimentation without bearing the full cost of sticking with it long enough to measure results. What this really suggests is that policy instability can become its own harm factor, because people who use drugs and their support networks plan around what they believe the system will do next.
Here’s a thought experiment: imagine a fire department that improves response time one year, then cuts funding the next because it didn’t “feel” like it was working fast enough. That’s analogous to how punitive or rollback-oriented governance can undermine public health strategies.
Why this moment feels different
This week’s warning is part of a larger ecosystem of signals—more 911 calls, more emergency-room visits, uncertain toxicology, and reports of shifting supply. Personally, I think what makes it stand out is the combination of institutional observation (health authority metrics) and community observation (patterns noticed by users). When those align, it’s a sign that the crisis isn’t just statistical—it’s experienced.
It also hints at a supply chain adapting to controls. If certain methods of enforcement or harm reduction encourage suppliers to alter composition, the toxic landscape will keep mutating. One thing that immediately follows is the deeper question: are current policy tools reducing harm overall, or are they simply changing the shape of the danger?
What we should do next
From my perspective, the next steps shouldn’t only be “more warnings.” Warnings inform, but they don’t reduce harm by themselves. We need interventions that treat uncertainty as the central threat.
Practical directions that follow logically from the situation include:
- Expand drug checking access in areas like Surrey and White Rock so people can reduce guesswork.
- Strengthen emergency response readiness for sedative-heavy overdoses, not just opioid reversal.
- Ensure community voices (like those from the Surrey Union of Drug Users) inform program design, because they observe changes faster than most bureaucracies.
- Maintain policy continuity long enough to evaluate what actually reduces deaths, rather than rolling back after short political cycles.
Personally, I think the hardest part is accepting that this isn’t a one-time fix. The illicit market will continue to evolve, so the public health response must be adaptive in real time—not just reactive after bodies are counted.
The broader perspective I take is simple: when a system repeatedly declares emergencies yet keeps losing thousands of lives, it means we’re confronting a crisis with tools that don’t match the crisis’ dynamics. In my opinion, this week’s warning is a reminder that safety requires more than messaging—it requires structural support, flexibility, and trust built with the people closest to the risk.
If you want, I can rewrite this into a shorter op-ed format (800–1000 words) or a longer analytical magazine style (1500–2000 words). Which length and tone would you prefer?
